⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LXEO News
Lexeo Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
LXEO
Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia
globenewswire.com
LXEO
Lexeo Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
globenewswire.com
LXEO
Form 8-K
sec.gov
LXEO
Lexeo Therapeutics Reports First Quarter 2026 Financial Results and Operational Highlights
globenewswire.com
LXEO
Form 8-K
sec.gov
LXEO
VRTX
ALNY
MRK
TSHA
Lexeo Therapeutics Announces Multiple Presentations at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
globenewswire.com
LXEO
Form 8-K
sec.gov
LXEO
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
globenewswire.com
LXEO
Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference
globenewswire.com
LXEO